Comgest Global Investors S.A.S. reduced its holdings in shares of Cerner Co. (NASDAQ:CERN) by 49.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 75,700 shares of the company’s stock after selling 75,400 shares during the quarter. Comgest Global Investors S.A.S.’s holdings in Cerner were worth $5,101,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the stock. Baird Financial Group Inc. increased its position in Cerner by 38.2% during the 4th quarter. Baird Financial Group Inc. now owns 14,715 shares of the company’s stock valued at $992,000 after buying an additional 4,064 shares in the last quarter. Norinchukin Bank The increased its position in Cerner by 7.7% during the 4th quarter. Norinchukin Bank The now owns 25,249 shares of the company’s stock valued at $1,702,000 after buying an additional 1,804 shares in the last quarter. FDx Advisors Inc. increased its position in Cerner by 15.4% during the 4th quarter. FDx Advisors Inc. now owns 22,500 shares of the company’s stock valued at $1,516,000 after buying an additional 3,005 shares in the last quarter. ARP Americas LP increased its position in Cerner by 128.9% during the 4th quarter. ARP Americas LP now owns 6,680 shares of the company’s stock valued at $450,000 after buying an additional 3,762 shares in the last quarter. Finally, Synovus Financial Corp increased its position in Cerner by 2.8% during the 4th quarter. Synovus Financial Corp now owns 46,306 shares of the company’s stock valued at $3,114,000 after buying an additional 1,241 shares in the last quarter. 81.63% of the stock is currently owned by institutional investors.
CERN has been the topic of several recent analyst reports. Zacks Investment Research raised Cerner from a “sell” rating to a “hold” rating in a research report on Tuesday, December 26th. Stifel Nicolaus reaffirmed a “hold” rating on shares of Cerner in a research report on Wednesday, November 22nd. BidaskClub lowered Cerner from a “buy” rating to a “hold” rating in a research report on Friday, December 22nd. JPMorgan Chase & Co. lowered Cerner from an “overweight” rating to a “neutral” rating in a research report on Friday, October 27th. Finally, Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a research report on Wednesday, October 25th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $67.05.
Cerner Co. (NASDAQ:CERN) opened at $64.22 on Tuesday. The company has a quick ratio of 2.99, a current ratio of 3.01 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $21,359.40, a PE ratio of 24.99, a PEG ratio of 1.92 and a beta of 0.90. Cerner Co. has a 1-year low of $54.01 and a 1-year high of $73.86.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.61 earnings per share. sell-side analysts anticipate that Cerner Co. will post 2.42 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This report was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.chaffeybreeze.com/2018/02/20/cerner-co-cern-position-cut-by-comgest-global-investors-s-a-s.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.